Shares of Elevance Health Inc. ELV slipped 2.09% to $376.53 Monday, on what proved to be an all-around positive trading ...

Elevance Health’s first quarter was characterized by notable revenue growth and a positive market reaction, driven by strong momentum across its Carelon services platform and ongoing investments in ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

The DJS Law Group reminds investors of a class action lawsuit against Elevance Health, Inc. ("Elevance" or "the Company") ...

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $505.0, a high estimate of $529.00, and a low estimate of $478.00. Highlighting a 0.86% decrease, the current ...

Access Elevance Health stock price history with daily data, historical prices, all-time highs, and stock chart history. Download and analyze trends easily.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services ...

HaloMD, a billing dispute consulting company, is denying allegations leveled against it in a lawsuit filed by a subsidiary of ...

The stock's rise snapped a three-day losing streak.

Elevance Health executives sought to ease the minds of skittish investors on Wall Street Tuesday, saying that while medical costs in Medicare Advantage remain elevated—following with an ongoing ...